Search - tctmd.com

Displaying 1 - 20 of 152

Sort: Relevancy | Date

Presentation TCT 2025

Insights into PAD Pathogenesis from LIFE-BTK Substudies

Presenter: Sahil A. Parikh

October 28, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

Presentation TCT 2025

TCT 1034: Comparison of Novel ClotIQ Quantification Software to Traditional Thrombus Evaluation Methods for Thrombectomy Procedure Planning

Presenter: Sahil A. Parikh

October 26, 2025

Presentation TCT 2025

Three-Year Outcomes of the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit™ BTK Drug-Eluting Resorbable Scaffold for Treatment of Infrapopliteal Lesions

Presenter: Sahil A. Parikh

October 26, 2025

Presentation TCT 2025

State of the Art BTK Drug Delivery: Do We Know What Works and When Will We Have the Evidence?

Presenter: Sahil A. Parikh

October 26, 2025

Presentation TCT 2025

Access Site Hemorrhage – Getting Control of the Bleeder

Presenter: Sahil A. Parikh

October 26, 2025

Presentation TCT 2024

Insights and Innovations in Scaffold Technologies for Peripheral Intervention: Bioresorbable and Metal Scaffolds Are The Answer

Presenter: Sahil Parikh

October 30, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

Presentation TCT 2024

Real-World Study of IVL in Challenging BTK Lesions: Acute Results of the Disrupt BTK II Study

Presenter: Sahil Parikh

October 29, 2024

News Conference News TCT 2024

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

Todd Neale

October 29, 2024

Presentation TCT 2024

Drug Delivery Technologies for the SFA: Where are We Now After the Paclitaxel Scare?

Presenter: Sahil Parikh

October 28, 2024

Presentation TCT 2024

Cost Effectiveness of Drug-Eluting Resorbable Scaffold Versus Angioplasty for Infrapopliteal Artery Disease From the LIFE-BTK Trial

Presenter: Sahil Parikh

October 28, 2024

Presentation TCT 2023

LIFE-BTK: The Top Line Results and Beyond

Presenter: Sahil Parikh

October 25, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

Presentation TCT 2023

CAT RX Technology Product Overview and Case Presentations

Presenter: Sahil Parikh

October 25, 2023

Presentation TCT 2023

Why Should a Cardiologist Care About Pulmonary Embolism?

Presenter: Sahil Parikh

October 25, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

Presentation TCT 2023

Ionir Ultrathin Polymer Mesh DES

Presenter: Sahil Parikh

October 24, 2023

Presentation TCT 2022

Drug Elution: Challenges and Opportunities

Presenter: Sahil Parikh

September 18, 2022

Presentation TCT 2022

Opportunities to Improve Outcomes: IVUS

Presenter: Sahil Parikh

September 17, 2022

Advertisement

Insights into PAD Pathogenesis from LIFE-BTK Substudies

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

TCT 1034: Comparison of Novel ClotIQ Quantification Software to Traditional Thrombus Evaluation Methods for Thrombectomy Procedure Planning

Three-Year Outcomes of the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit™ BTK Drug-Eluting Resorbable Scaffold for Treatment of Infrapopliteal Lesions

State of the Art BTK Drug Delivery: Do We Know What Works and When Will We Have the Evidence?

Access Site Hemorrhage – Getting Control of the Bleeder

Insights and Innovations in Scaffold Technologies for Peripheral Intervention: Bioresorbable and Metal Scaffolds Are The Answer

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

Real-World Study of IVL in Challenging BTK Lesions: Acute Results of the Disrupt BTK II Study

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

Drug Delivery Technologies for the SFA: Where are We Now After the Paclitaxel Scare?

Cost Effectiveness of Drug-Eluting Resorbable Scaffold Versus Angioplasty for Infrapopliteal Artery Disease From the LIFE-BTK Trial

LIFE-BTK: The Top Line Results and Beyond

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

CAT RX Technology Product Overview and Case Presentations

Why Should a Cardiologist Care About Pulmonary Embolism?

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

Ionir Ultrathin Polymer Mesh DES

Drug Elution: Challenges and Opportunities

Opportunities to Improve Outcomes: IVUS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content